Associations between IL-23R gene polymorphism (rs10889677 A/C) and ankylosing spondylitis and rheumatoid arthritis susceptibility: A meta-analysis with trial sequential analysis

References

• Tkachenko O, Lapin S, Maslyansky A, et al. Influence of HLA-DRB1 susceptibility alleles on the autoantibodies spectrum of systemic lupus erythematosus in European part of Russia. Autoimmun Rev. 2019;18(5):558–560.
   PubMedGoogle Scholar
• Rose NR. Prediction and prevention of autoimmune disease in the 21st century: a review and preview. Am J Epidemiol. 2016;183(5):403–406.
   PubMed Web of Science ®Google Scholar
• Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health. 2000;90(9):1463–1466.
   PubMed Web of Science ®Google Scholar
• Han R, Xia Q, Xu S, et al. Interleukin-23 receptor polymorphism (rs10889677 A/C) in ankylosing spondylitis: meta-analysis in Caucasian and Asian populations. Clin Chim Acta. 2018;477:53–59.
   PubMed Web of Science ®Google Scholar
• Gomes DSI, Angelo HD, Rushansky E, et al. Interleukin (IL)-23 receptor, IL-17A and IL-17F gene polymorphisms in Brazilian patients with rheumatoid arthritis. Arch Immunol Ther Exp. 2017;65(6):537–543.
   PubMedGoogle Scholar
• Karaderi T, Harvey D, Farrar C, et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology. 2009;48(4):386–389.
   PubMed Web of Science ®Google Scholar
• Pimentel-Santos FM, et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol. 2009;27(5):800–806.
   PubMed Web of Science ®Google Scholar
• Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11):1329–1337.
   PubMed Web of Science ®Google Scholar
• Szabo M, Safrany E, Pazar B, et al. Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitis. Mol Biol Rep. 2013;40(1):359–363.
   PubMedGoogle Scholar
• Temel S, Balkarli A, Tepeli E, et al. AB0019 comparison of IL-23 receptor gene polymorphisms in patients with primary Sjögren syndrome, ankylosing spondylitis, and ankylosing spondylitis with Sjogren's syndrome. Ann Rheum Dis. 2015;74(Suppl 2):897.2–897.
   Google Scholar
• Rueda B, Orozco G, Raya E, et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2008;67(10):1451–1454.
   PubMed Web of Science ®Google Scholar
• Sáfrány E, Pazár B, Csöngei V, et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples. Scand J Immunol. 2009;70(1):68–74.
   PubMed Web of Science ®Google Scholar
• Rahman P, Inman RD, Gladman DD, et al. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 2008;58(4):1020–1025.
   PubMed Web of Science ®Google Scholar
• Bettencourt BF, Rocha FL, Alves H, et al. Protective effect of an ERAP1 haplotype in ankylosing spondylitis: investigating non-MHC genes in HLA-B27-positive individuals. Rheumatology. 2013;52(12):2168–2176.
   PubMed Web of Science ®Google Scholar
• Wu X. Study on the relationship between IL-23R genetic variation, Th17 cells and ankylosing spondylitis. Shanghai: Second Military Medical University; 2008.
   Google Scholar
• Zhou L, Lai B, Huang CB, et al. Association of IL23R gene polymorphism with the risk of ankylosing spondylitis in Beijing population. J Ningxia Med Univ. 2012;34(06):548–552 + 540.
   Google Scholar
• Zhu XQ. Etiological study on DA2B in candidate gene association studies of ankylosing spondylitis in Northern China. Beijing: University of Chinese Union Medical Sciences; 2009.
   Google Scholar
• Wong R, Wei JC, Huang C, et al. Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis. J Rheumatol. 2012;39(1):135–140.
   PubMed Web of Science ®Google Scholar
• Su S-S, Wang S-L, Lu L-J, et al. Association of interleukin-23 receptor gene single nucleotide polymorphisms with ankylosing spondylitis. Ann Clin Lab Sci. 2016;46(5):470–473.
   PubMed Web of Science ®Google Scholar
• Chen C, Zhang X, Li J, et al. Associations of IL-23R polymorphisms with ankylosing spondylitis in east Asian population: a new case-control study and a meta-analysis. Int J Immunogenet. 2012;39(2):126–130.
   PubMed Web of Science ®Google Scholar
• Yang B, Xu Y, Liu X, et al. IL-23R and IL-17A polymorphisms correlate with susceptibility of ankylosing spondylitis in a southwest Chinese population. Oncotarget. 2017;8(41):70310–70316.
   PubMedGoogle Scholar
• Sung IH, Kim TH, Bang SY, et al. IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol. 2009;36(5):1003–1005.
   PubMed Web of Science ®Google Scholar
• Qian B, Jiang J, Ji M, et al. Lack of associations between two previously identified susceptible single nucleotide polymorphisms of interleukin-23 receptor gene and ankylosing spondylitis: a replication study in a Chinese Han population. BMC Musculoskelet Disord. 2013;14(1):190.
   PubMedGoogle Scholar
• Xie QY, Wei M, Fu PL, et al. The correlation between interleukin 23 receptor gene polymorphism and rheumatoid arthritis. Clin Focus. 2016;31(01):40–44.
   Google Scholar
• Li H. Association between immune gene polymorphism and genetic susceptibility to rheumatoid arthritis in Han population. Chongqing: Third Military Medical University; 2009.
   Google Scholar
• Faragó B, Magyari L, Sáfrány E, et al. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis: Table 1. Ann Rheum Dis. 2008;67(2):248–250.
   PubMed Web of Science ®Google Scholar
• Soysal E, Ulutaş F, Tepeli E, et al. IL-23R gene polymorphisms in rheumatoid arthritis. Rheumatol Int. 2022;42(3):555–562.
   PubMedGoogle Scholar
• Orozco G, Rueda B, Robledo G, et al. Investigation of the IL23R gene in a Spanish rheumatoid arthritis cohort. Hum Immunol. 2007;68(8):681–684.
   PubMedGoogle Scholar
• Hamdy G, Darweesh H, Khattab EA, et al. Evidence of association of interleukin-23 receptor gene polymorphisms with Egyptian rheumatoid arthritis patients. Hum Immunol. 2015;76(6):417–420.
   PubMedGoogle Scholar
• Paradowska-Gorycka A, Malinowski D, Haladyj E, et al. Lack of association between rheumatoid arthritis and genetic variants rs10889677, rs11209026 and rs2201841 of IL-23R gene. Med Clin. 2018;151(5):191–195.
   PubMedGoogle Scholar
• Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198(12):1951–1957.
   PubMed Web of Science ®Google Scholar
• Deveci H, Turk A, Ozmen Z, et al. Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients. Cent Eur J Immunol. 2019;44(4):433–439.
   PubMedGoogle Scholar
• He YG, Jin L, Huang W. Research progress of single nucleotide polymorphism and linkage disequilibrium. Basic Clin Med. 2004;05:487–490.
   Google Scholar
• Chen CH, Liu ZH, Guan TJ, et al. Distribution characteristics of interleukin-1 receptor antagonist gene polymorphism in normal population. Chin J Nephrol Dial Transpl. 1997;05:25–27–+102.
   Google Scholar
• He X, Liu R, Fan T, et al. Treating autoimmune diseases by targeting IL-23 with gene-silencing pyrrole-imidazole polyamide. J Immunol. 2020;204(8):2053–2063.
   PubMedGoogle Scholar